Dongcheng Pharmaceutical to develop new drugs with universities

Dongcheng Pharmaceutical announced that the company recently signed a technology transfer contract and a technology development (cooperation) contract with Peking University and Kunming Institute of Botany of the Chinese Academy of Sciences.

Dongcheng Pharmaceutical announced that the company recently signed a technology transfer contract and a technology development (cooperation) contract with Peking University and Kunming Institute of Botany of the Chinese Academy of Sciences.

The three parties will jointly participate in the research and development of a new-target antithrombotic innovative drug called DCP118.

Upon completion of the development, the company will have exclusive rights to DCP118’s global patents, clinical development and registration, production and marketing.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/04/21/dongcheng-pharmaceutical-to-develop-new-drugs-with-universities/.

Leave a Reply

Please Login to Comment